This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual and sustainability report for a better understanding of these risks and uncertainties.
Interim Report Q1 2023
Strategic review of ownership of Vinda and Consumer Tissue Private Label Europe
Strategic Review
Strategic review of ownership in Vinda and Consumer Tissue Private Label Europe initiated
Aim of reducing Consumer Tissue's share of the Company's total sales
Includes exploring different options and may result in divestments, although no such decisions have yet been taken
Interim Report Q1 2023
Essity
Net Sales 2022
Vinda, 16%
SEK
~156bn
Consumer
Tissue Private
Label Europe, 6%
April 27, 2023
4
Vinda
Listed on Hong Kong Stock Exchange
Market capitalization of HKD 26bn (SEK 34bn) at the end of trading on April 25
Essity ownership 51.59% and Essity consolidates 100%
Essity AB (publ) published this content on 27 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2023 07:07:07 UTC.
Essity AB is one of the world's leading manufacturers of hygiene products. Net sales break down by family of products as follows:
- human care products (40.3%): incontinence products (Tena), feminine protection products (Libresse, Bodyform, Nana, Nuvenia, Saba, Nosotras, Donnasept, etc.), diapers (Libero, Up & Go, Libero-Peaudouce, Drypers, Pequenin, etc.), compresses and bandages.
- paper hygiene products (32.6%): paper towels, toilet paper, handkerchiefs, wipes, etc. sold under Tempo, Colhogar, Cozy, Cushelle, Danke, Delica, Demak Up, Favorita, Flen, Lotus, Lovly, Okay, Plenty, Regio and Zewa brands;
- professional hygiene products (26.8%): including toilet paper, handkerchiefs, hand lotions and hand soaps, hand sanitizers, as well as cleaning and wiping products;
- other (0.3%).
At the end of 2023, the group operated around 70 production sites in the world.
Net sales are distributed geographically as follows: Europe (60.3%), North America (17.4%), Latin America (17.1%), Asia (1.6%), and other (3.6%).
ESSITY AB 
